Skip navigation

Collaborative Approaches for Risk Sharing, Population Health Management and Data-Driven Product Advancement

August 15-16, 2018
  • Philadelphia, PA

As health systems continue to grow and merge to form larger Integrated Delivery Networks (IDNs), manufacturers are tasked with learning how to best contract with, and meet the needs of, these increasingly complex systems. With conflict of interest policies in place and restricted access to physicians, manufacturers are changing their sales approaches to better reach and engage these complex customers.

CBI’s 3rd Annual Partnering with IDNs BioPharma Strategy Summit convenes manufacturers and integrated delivery networks to discuss how to create a mutually beneficial partnership for data-driven product advancement, greater patient engagement and optimal care coordination.

Take Your Health System Strategy to the Next Level with Dynamic Sessions:

  • Engage with industry pioneers at this highly collaborative event and benefit from 5+ hours of dedicated networking opportunities
  • Learn new sales models for engaging large hospital systems and IDNs
  • Hear case studies around system care coordination and population health management
  • Analyze the impact of an outcomes-driven marketplace for payers and providers
  • Take away contracting strategies that provide the most value to organized customers
  • Initiate and nurture network-based relationships
  • Overcome the challenges of specialty data management
  • And more!

Previous Attendee Acclaim:

This conference was a success due to the great speakers and the engaged participants. I am looking forward to collaborating and continuing the conversation next year at the next round
of “Partnering with IDN” conferences

Director, Team Leader, U.S. Payer Channel Access, Pfizer, Inc

Most informative and collaborative conference I’ve been to in years. It is one of the most thought-provoking events. Thank you so much for all your hard work and attention to
quality of content and speakers.

Founding Partner, Blue Fin Group

Always get so much out of these sessions and
they get better every time.

Senior Manager, Organized Customer Group Commercial Excellence, Sanofi

Well organized and good speaker selection.

Assistant Director, Specialty Pharmacy Services, University of Illinois

The knowledge base and experience of the attendees exceeded my expectations. The conference truly was a
working session more than a speaker’s conference.

Principal/Chief Operating Officer, Curant Health

The conference helped me understand the needs for all stakeholders. Manufacturers and IDNS can help each other and improve outcomes for patients as specialty drugs continue to grow as a percentage of pharmacy budgets.

Senior Director, Acentrus

Strong conference, great insights.

Principal and COE Lead, IDNs, IMS Health

Having a conference dedicated to pharma/IDN partnering opportunities validates the importance of the IDN in
the U.S. evolving health care model.

Anonymous

Some of the biggest changes in the healthcare space are occurring around IDNs, ACOs and payers. This is a dynamic part of the market and this conference provides relevant
content and perspectives surrounding it.

Head of Global MDM, Lexis Nexis